Skip to content
Screener

Beta Bionics BBNX Q1 2026 earnings

Reported April 21, 2026 · After market close

Revenue$27.6MBeat by $678.2K
EPS-$0.49Beat by $0.04
Revenue estimate$26.9M
EPS estimate-$0.53

Next report

Oct 27, 2026 (in 2 months)
Revenue estimate$35.0M
EPS estimate-$0.55

Financials

Q1 2026

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$444.71M—
Enterprise value$421.42M—
P/S4×—

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%—
Debt / equity0×0.0×
Current ratio10.7×-5.2×

Segments

By product

See full
Single Use Products$10.2M+144%
I Let$10.1M+4.8%

By geography

See full
Non Us-—

FAQ

When did Beta Bionics report Q1 2026 earnings?
Beta Bionics (BBNX) reported Q1 2026 earnings on April 21, 2026 after market close.
What were Beta Bionics's Q1 2026 revenue and EPS?
Beta Bionics reported revenue of $27.6M and eps of $-0.49 for Q1 2026.
Did Beta Bionics beat estimates in Q1 2026?
Revenue beat the consensus estimate of $26.9M by $678.2K. EPS beat the consensus estimate of $-0.53 by $0.04.
How did Beta Bionics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 56.6% from $17.6M a year earlier and eps grew 5.8% from $-0.52.
Where can I find Beta Bionics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001171843-26-002614) and the 10-Q periodic report (0001193125-26-166843) directly on SEC EDGAR. The filing index links above go to sec.gov.